Kennedy's Follow-On Biologics Revisions Add Anti-"Evergreening" Language

Restrictions are similar to those in Rep. Waxman's bill, but less specific.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet